Psychological well-being in early rheumatoid arthritis:
|
|
- Hope Williamson
- 7 years ago
- Views:
Transcription
1 Psychological well-being in early rheumatoid arthritis: Findings from the Early Rheumatoid Arthritis Network (ERAN) Sam Norton,* Patrick Kiely, David Walsh, Richard Williams & Adam Young *Cambridge Institute of Public Health 2 May 2012
2 Background Psychological well-being in rheumatoid arthritis is known to be reduced compared to the general population (Dickens et al, 2002) Longitudinal studies suggest that it is stable over time (e.g. Barlow et al, 1998; Brekke et al, 2003) However, some evidence that it is lower early in the course of the disease (Odegard et al, 2007; Schieir et al, 2009; Norton et al, 2011) Aim: To examine longitudinal changes in psychological well-being in a large sample of patients with recent onset RA Identify factors related to psychological well-being at presentation and changes in psychological well-being over time
3 Early Rheumatoid Arthritis Network (ERAN) Prospective observational cohort recruiting DMARD naïve patients at presentation from 21 centres in the UK and Ireland In total, 1235 patients were recruited between 2002 and September 2011 Patients were re-assessed after 3-6 months, 12 months and then yearly Available data over 5-years was used: N base = 1235, N 3-6m = 922, N 12m = 860, N 24m = 712, N 36m = 576, N 48m = 458, N 60m = 314
4 Psychological well-being Quality of life was assessed using the SF36v2 Used SF36 Mental Health (SF36-MH) scores as markers of psychological well-being Scores were normed against the UK general population (mean=50, SD=10) Missing SF36 data around 20% at each visit, and 10% have no SF36-MH score recorded at any visit
5 Baseline demographic and clinical characteristics N Mean Std. Dev. Age Female % HAQ DAS Tender joints Swollen joints ESR CRP
6 Mean psychological well-being over time 51 Normed SF36-MH score N= Disease duration (years)
7 Mixed-effects model Linear mixed-effects model for change in psychological well-being over time N = 1108 with at least one SF36-MH score Random intercept: Mean = 47.1; SD = 7.1 Random slope: Mean = 0.5; SD = 1.1 Baseline level Rate of change b 95% CI b 95% CI Age 0.09 ( 0.06, 0.13 ) ( -0.04, 0.00 ) Female ( -1.71, 0.55 ) ( -0.55, 0.30 ) BMI 0.04 ( -0.06, 0.14 ) ( -0.08, 0.00 ) Smoker ( -1.44, 0.67 ) 0.03 ( -0.40, 0.47 ) HAQ ( -3.11, ) ( -0.45, 0.40 ) DAS ( -0.79, 0.19 ) 0.01 ( -0.19, 0.21 ) CRP 1.00 ( 0.26, 1.75 ) ( -0.42, 0.23 ) Erosions 0.53 ( -0.56, 1.62 ) ( -0.41, 0.39 ) SF36 vitality 0.45 ( 0.39, 0.51 ) ( -0.09, )
8 Mean psychological well-being over time: Age Normed SF36-MH score Age mean mean - 1SD mean + 1SD Disease duration (years) Note: Mean = 57.1; SD = 14.0
9 Mean psychological well-being over time: BMI Normed SF36-MH score BMI mean mean - 1SD mean + 1SD Disease duration (years) Note: Mean = 27.6; SD = 5.3
10 Mean psychological well-being over time: Vitality Normed SF36-MH score SF36 vitality mean mean - 1SD mean + 1SD Disease duration (years) Note: Mean = 41.7; SD = 11.1
11 Conclusion Psychological well-being in early RA, prior to the use of disease modifying therapy, is reduced compared to the general population Over time psychological well-being normalises but takes longer in those who are younger, have higher BMI and report lower baseline vitality While baseline disease characteristics, mainly HAQ, explain differences in baseline psychological well-being they are not related to change over time
12 Acknowledgments ERAN Centres Clinician Metrologist Aylesbury Dr M Webley/Dr S Edmonds J Hall Basingstoke Dr P Prouse S Andrews Bristol Dr P Creamer J Taylor/G Bath Christchurch Dr C Dunne L Hawley Enfield Dr J Griffin P Goodman Haverfordwest Dr A Coulson/Dr S Sunil S Morris Hereford Dr R Williams K Blunn/J McDowell/H Robinson Lancaster Dr M Bukhari/Dr J Halsey B Evans/J Kaye GKT, London Dr E Choy R Chura St Georges, London Dr P Kiely F Leone Mansfield Dr D Walsh & Dr N Carter D Wilson Oxford Dr J David M Cox St Albans Dr A Young A Seymour Stoke-on-Trent Dr A Hassell M Kirwan Waterford, Ireland Dr J Devlin C Duffy Weston-super-Mare Dr S Clarke/Dr S Green B Williams Yeovil Dr T Palferman/Dr S Knights C Buckley/R Rowland-Axe Collaborators Medical Research Council (MRC) Clinical Trials Unit, London Project Coordinator Marie Hunt Rheumatology Research & Audit Office St Albans City Hospital Waverley Road St Albans, Herts AL3 5PN ENGLAND Tel: (+44) marie.hunt@whht.nhs.uk Health Care Commission The Healthcare Commission exists to promote improvements in the quality of healthcare and public health in England and, to a lesser degree, Wales. In England, the Commission is responsible for assessing and reporting on the performance of both NHS and independent healthcare organisations, to ensure that they are providing a high standard of care. We also encourage providers to continually improve their services and the way they work.
Improvement in Quality of Life of Rheumatoid Arthritis Patients on Biologic Therapy
Improvement in Quality of Life of Rheumatoid Arthritis Patients on Biologic Therapy R Adams 1, Ct Ng 2, A Gibbs 2, L Tilson 1, D Veale 2, B Bresnihan 2, O FitzGerald 2, M Barry 1 1. National Centre for
More informationA patient and public guide to the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis
A patient and public guide to the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis 1st Annual Report 2015 (Data collection: 1 February 2014 30 April 2015) 2 Contents Background Who
More informationDeveloping a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe
Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe Chair Clinical Affairs Committee, BSR Outline The British Society for Rheumatology Challenges in improving patient outcomes
More informationRheumatology Advance Access published November 15, 2013. Work disability and state benefit claims in early rheumatoid arthritis: the ERAN cohort
Rheumatology Advance Access published November 15, 2013 RHEUMATOLOGY 53 Original article doi:10.1093/rheumatology/ket373 Work disability and state benefit claims in early rheumatoid arthritis: the ERAN
More informationEarly identification and treatment - the Norwegian perspective. Till Uhlig Dept of Rheumatology Diakonhjemmet Hospital Oslo, Norway
Early identification and treatment - the Norwegian perspective Till Uhlig Dept of Rheumatology Diakonhjemmet Hospital Oslo, Norway Oslo Rheumatoid Arthritis Registry (ORAR) Very early Arthritis Clinic
More informationNew Evidence reports on presentations given at EULAR 2012. Rituximab for the Treatment of Rheumatoid Arthritis
New Evidence reports on presentations given at EULAR 2012 Rituximab for the Treatment of Rheumatoid Arthritis Report on EULAR 2012 presentations Long-term safety of rituximab: 10-year follow-up in the
More informationDAS28 criteria for initiation of biologics in early RA: a clinician s view. Dr Patrick Kiely St George s Healthcare NHS Trust, London
DAS28 criteria for initiation of biologics in early RA: a clinician s view Dr Patrick Kiely St George s Healthcare NHS Trust, London History: NICE (E&W) guidelines for starting anti-tnf agents April 2001
More informationSYNOPSIS. 2-Year (0.5 DB + 1.5 OL) Addendum to Clinical Study Report
Name of Sponsor/Company: Bristol-Myers Squibb Name of Finished Product: Abatacept () Name of Active Ingredient: Abatacept () Individual Study Table Referring to the Dossier (For National Authority Use
More information1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:
1.0 Abstract Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA Keywords Rationale and Background: This abbreviated clinical study report is based on a clinical surveillance
More informationDr Sarah Levy Consultant Rheumatology Croydon University Hospital
Dr Sarah Levy Consultant Rheumatology Croydon University Hospital Contents Definition/ epidemiology Diagnosis Importance of early diagnosis/ treatment Guidelines Evidence based treatment protocol Current
More informationImproving healthcare for people with long-term conditions
Improving healthcare for people with long-term conditions UWe-book: Number Two 1 Health and Well-being At UWE our research and development is real and dynamic, identifying problems and providing solutions
More informationLinking biobanks to registries: Why and how? Anne Barton
Linking biobanks to registries: Why and how? Anne Barton Biobanks why should we collect samples? Anti-TNF treatment in RA Cost approx. 8,000/person/year 30-40% RA patients do not respond Rare, serious
More informationPredictors of Physical Therapy Use in Patients with Rheumatoid Arthritis
Predictors of Physical Therapy Use in Patients with Rheumatoid Arthritis Maura Iversen,, PT, DPT, SD, MPH 1,2,3 Ritu Chhabriya,, MSPT 4 Nancy Shadick, MD 2,3 1 Department of Physical Therapy, Northeastern
More informationMethotrexate Is Not Disease Modifying In Psoriatic Arthritis
Methotrexate Is Not Disease Modifying In Psoriatic Arthritis A New Treatment Paradigm Is Required Gabrielle H Kingsley*, Jonathan Packham, Neil McHugh, Diarmuid Mulherin George Kitas, Kuntal Chakravarty,
More informationFamily Focused Therapy for Bipolar Disorder (Clinical Case Series) Participant Information Sheet
Family Focused Therapy for Bipolar Disorder (Clinical Case Series) Participant Information Sheet Study Title: Family Focused Therapy for Bipolar Disorder: A Clinical Case Series) We would like to invite
More informationRheumatoid Arthritis www.arthritis.org.nz
Rheumatoid Arthritis www.arthritis.org.nz Did you know? RA is the second most common form of arthritis Approximately 40,000 New Zealanders have RA RA can occur at any age, but most often appears between
More informationLeflunomide Date: 26 June 2008
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationA Survey of Barriers to Treatment Access in Rheumatoid Arthritis. Country Annex Report: UK
A Survey of Barriers to Treatment Access in Rheumatoid Arthritis Country Annex Report: UK October 2009 1 Interviews In the UK, five rheumatologists and one patient representative were interviewed. The
More informationPROMS: Patient Reported Outcome Measures. The Role, Use & Impact of PROMs on Nursing in the English NHS
POLICY AND INTERNATIONAL DEPARTMENT Policy Briefing 1/11 PROMS: Patient Reported Outcome Measures The Role, Use & Impact of PROMs on Nursing in the English NHS Patient Reported Outcomes Measures (PRO or
More informationPredictors of recovery and legal representation in a compensation setting 12 months post injury: The Whiplash Outcome Study [WOS]
Predictors of recovery and legal representation in a compensation setting 12 months post injury: The Whiplash Outcome Study [WOS] Petrina Casey [PhD candidate], Rehabilitation Studies Unit, Sydney Medical
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) September 2014 Review date: September 2017 Bulletin 203: Tocilizumab (subcutaneous) in combination with methotrexate or as monotherapy for the treatment
More informationEtanercept (Enbrel ) in Patients with Rheumatoid Arthritis with Recent Onset Versus Established Disease: Improvement in Disability
Etanercept (Enbrel ) in Patients with Rheumatoid Arthritis with Recent Onset Versus Established Disease: Improvement in Disability SCOTT W. BAUMGARTNER, ROY M. FLEISCHMANN, LARRY W. MORELAND, MICHAEL H.
More informationFoundation Programme 2014 Recruitment Stats and Facts Final report December 2014
Foundation Programme 2014 Recruitment Stats and Facts Final report December 2014 Summary information for FP and AFP 2014 recruitment 1. Applications submitted: A total of 7974 applications were submitted,
More informationUnderstanding and improving communications between people with rheumatoid arthritis and their healthcare professionals. RCUKCOMM00116w February 2014
Understanding and improving communications between people with rheumatoid arthritis and their healthcare professionals RCUKCOMM00116w February 2014 This project has been funded by Roche Products Ltd &
More informationUK Society for Behavioural Medicine 9 th Annual Scientific Meeting
UK Society for Behavioural Medicine 9 th Annual Scientific Meeting Behavioural Medicine: From Laboratory to Policy University of Oxford Examination Schools Monday 9 and Tuesday 10 December 2013 NPRI UK
More informationMedical Policy Manual. Topic: Vectra DA Blood Test for Rheumatoid Arthritis Date of Origin: June 2014
Medical Policy Manual Topic: Vectra DA Blood Test for Rheumatoid Arthritis Date of Origin: June 2014 Section: Laboratory Last Reviewed Date: June 2014 Policy No: 67 Effective Date: September 1, 2014 IMPORTANT
More informationSSNAP s Acute Organisational Audit Report 2012: Performance Summary for South London
SSNAP s Acute Organisational Audit Report 2012: Performance Summary for South London The Sentinel Stroke National Audit Programme (SSNAP) s Acute Organisational Audit looks at how stroke services across
More informationVectra DA Blood Test for Rheumatoid Arthritis. Original Policy Date January /2014
MP 2.04.81 Vectra DA Blood Test for Rheumatoid Arthritis Medical Policy Section 2.0 Original Policy Date January /2014 Last Review Status/Date 1/2014 Disclaimer Our medical policies are designed for informational
More information2010 ACR/EULAR Classification Criteria for Rheumatoid Arthritis
2010 ACR/EULAR Classification Criteria for Rheumatoid Arthritis Published in the September 2010 Issues of A&Rand ARD Phases of the Project Phase 1 Data analysis Phase 2 Consensus process Predictors of
More informationPsoriasis, Incidence, Quality of Life, Psoriatic Arthritis, Prevalence
1.0 Abstract Title Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients with Psoriasis Severe or Moderate with Adalimumab Treatment (TOGETHER). Keywords Psoriasis,
More informationRHEUMATOID ARTHRITIS. Dr Bruce Kirkham Rheumatology Clinical Lead
RHEUMATOID ARTHRITIS Dr Bruce Kirkham Rheumatology Clinical Lead RHEUMATOID ARTHRITIS (RA) RA is a common disease: 0.8 per cent of the population RA more common in females: female to male ratio 3:1 RA
More informationTreating Rheumatoid Arthritis to Target : the patient version of the international recommendations
Treating Rheumatoid Arthritis to Target : the patient version of the international recommendations Data presented from the publication: M. de Wit, et al. Ann Rheum Dis. 2011;70:891-5. Epub Apr 7, 2011.
More information1. Title 2. Background
1. Title EARLY PsA Effectiveness of early Adalimumab therapy in psoriatic arthritis patients from Reuma.pt, the Rheumatic Diseases Portuguese Register, Portuguese RheumatoLogy SocietY (SPR) 2. Background
More informationDeveloping a database to support patient and public engagement (PPE) A DH PPI pathfinder project with Leeds South and East CCG
Developing a database to support patient and public engagement (PPE) A DH PPI pathfinder project with Leeds South and East CCG MSDi Overview History Established in 2000 by MSD to leverage emerging informatics
More informationSummary of the role and operation of NHS Research Management Offices in England
Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices
More informationLearning Disabilities
Learning Disabilities Positive Practice Guide January 2009 Relieving distress, transforming lives Learning Disabilities Positive Practice Guide January 2009 Contents 1. Background and policy framework
More informationDISEASE COURSE IN EARLY RHEUMATOID ARTHRITIS: AN OBSERVATIONAL STUDY
ORIGINAL ARTICLES DISEASE COURSE IN EARLY RHEUMATOID ARTHRITIS: AN OBSERVATIONAL STUDY Teodora Serban 1,2, Iulia Satulu 2, Oana Vutcanu 2, Mihaela Milicescu 1,2, Carina Mihai 1,2, Mihai Bojinca 1,2, Victor
More informationRoche s RoACTEMRA improved rheumatoid arthritis signs and symptoms significantly more than adalimumab as single-agent therapy
Media Release Basel, 6 June 2012 Roche s RoACTEMRA improved rheumatoid arthritis signs and symptoms significantly more than adalimumab as single-agent therapy Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced
More informationNational Rheumatoid Arthritis Society. THE ECONOMIC BURDEN OF RHEUMATOID ARTHRITIS March 2010
National Rheumatoid Arthritis Society THE ECONOMIC BURDEN OF RHEUMATOID ARTHRITIS March 2010 ABOUT NRAS NRAS provides support, information, education and advocacy for people with rheumatoid arthritis (RA)
More informationto Part of Dossier: Name of Active Ingredient: Title of Study: Quality of life study with adalimumab in rheumatoid arthritis. ESCALAR.
2.0 Synopsis Abbott Laboratories Name of Study Drug: Individual Study Table Referring to Part of Dossier: Adalimumab (HUMIRA) (For National Authority Use Only) Name of Active Ingredient: Adalimumab Title
More informationOncology Nursing Society Annual Progress Report: 2008 Formula Grant
Oncology Nursing Society Annual Progress Report: 2008 Formula Grant Reporting Period July 1, 2011 June 30, 2012 Formula Grant Overview The Oncology Nursing Society received $12,473 in formula funds for
More informationThe Vectra DA Test for Rheumatoid Arthritis
Medical Policy Manual Topic: Vectra DA Blood Test for Rheumatoid Arthritis Date of Origin: June 2014 Section: Laboratory Last Reviewed Date: May 2015 Policy No: 67 Effective Date: July 1, 2015 IMPORTANT
More informationBone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-ray Erosion Detection
Bone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-ray Erosion Detection Michael Tomizza, BSc, MSc Candidate October 15, 2014: Hamilton
More informationWhat factors determine poor functional outcome following Total Knee Replacement (TKR)?
Specific Question: What factors determine poor functional outcome following Total Knee Replacement ()? Clinical bottom line All groups derived benefit from undergoing a, reviews suggests that the decision
More informationOutline. Personal profile & research interests. Rheumatology research in Ireland. Current standing. Future plans
Outline Personal profile & research interests Rheumatology research in Ireland Current standing Future plans Personal profile 1983 MB Queens University 1990-3 ARUK Clinical Research Fellowship 1990-93
More informationLiving Breathing Property
Health Living Breathing Property 08449 02 03 04 gva.co.uk/health Client Chipping Norton Health Centre Location Oxfordshire Services Development Consultancy, Architectural Design, Project Management, Planning
More informationEffectiveness and Drug Adherence in Rheumatoid Arthritis Patients on Biologic Monotherapy: A prospective observational study in Southern Sweden
Effectiveness and Drug Adherence in Rheumatoid Arthritis Patients on Biologic Monotherapy: A prospective observational study in Southern Sweden Collaborators: Primary investigators Dr Lars Erik Kristensen,
More informationExercise therapy in the management of upper limb dysfunction in people with Rheumatoid Arthritis. Speaker declaration: no conflicts of interest
Exercise therapy in the management of upper limb dysfunction in people with Rheumatoid Arthritis Speaker declaration: no conflicts of interest Exercise a planned, structured and repetitive bodily movement
More informationInpatient and outpatient rehabilitation for patients with rheumatoid arthritis: a clinical and economic assessment
Journal of Medical Economics 0; 0: 00 00 0 Inpatient and outpatient rehabilitation for patients with rheumatoid arthritis: a clinical and economic assessment Norelee Kennedy PhD, Emma Stokes PhD, Eamon
More informationPsoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
More informationMH21 Child and Adolescent Mental Health Services Inquiry British Association for Counselling and Psychotherapy (BACP)
The would like to submit the following response to the Health and Sport Committee s Inquiry into child and adolescent mental health services. BACP BACP is the leading professional body for counselling
More informationFarr Institute of Health Informatics Research Harnessing Data for Health Science and e-health Innovation
Farr Institute of Health Informatics Research Harnessing Data for Health Science and e-health Innovation Georgina Evans Industry Engagement Manager Farr Institute Who is Farr? Diseases are more easily
More informationRheumatoid arthritis in England 1996 to 2004. Mortality trends
Rheumatoid arthritis in England 1996 to 2004. Mortality trends Authors: Michael Goldacre, Marie Duncan, Paula Cook-Mozaffari, Matthew Davidson, Henry McGuiness, Daniel Meddings Published by: Unit of Health-Care
More informationManaging Injuries of the Neck Trial (MINT) Simon Gates
Managing Injuries of the Neck Trial (MINT) Simon Gates Contents Background Study design Results Conclusions The MINT team Sallie Lamb Simon Gates Mark Williams Esther Williamson Emma Withers Martin Underwood
More informationIntegrating Physiotherapy and Occupational Therapy for Persons with Chronic Disease: Lessons Learned from Research in Primary Care
Integrating Physiotherapy and Occupational Therapy for Persons with Chronic Disease: Lessons Learned from Research in Primary Care Lori Letts & Julie Richardson School of Rehabilitation Science McMaster
More informationSelf-Management and Self-Management Support on Chronic Low Back Pain Patients in Primary Care
Self-Management and Self-Management Support on Chronic Low Back Pain Patients in Primary Care Jennifer Kawi, PhD, MSN, APN, FNP-BC University of Nevada, Las Vegas, School of Nursing Supported through UNLV
More informationThe association between health risk status and health care costs among the membership of an Australian health plan
HEALTH PROMOTION INTERNATIONAL Vol. 18, No. 1 Oxford University Press 2003. All rights reserved Printed in Great Britain The association between health risk status and health care costs among the membership
More informationClinically Actionable Biomarkers in Rheumatoid Arthritis
Clinically Actionable Biomarkers in Rheumatoid Arthritis PepTalk January 6, 2009 William Robinson, MD, PhD Stanford University School of Medicine VA Palo Alto Health Care System T cell mediated Autoimmune
More informationSUPPLEMENTARY DATA. PRIBA Study Group. Lead Centre:
PRIBA Study Group Lead Centre: Royal Devon and Exeter NHS Foundation Trust/University of Exeter: Anita Hill, Rob Bolt, Jane Stewart, Bridget Knight, Tim McDonald, Beverley Shields, Angus Jones, Andrew
More informationWelcome to. My plan for my life with
Welcome to My plan for my life with My details This book belongs to: If this book is found, please return it to: My diagnosis is: I also live with these medically diagnosed conditions: My NHS number is:
More informationLeicester Nuffield Research Unit Trends in disease and how they will impact on disability in the older population
Leicester Nuffield Research Unit Trends in disease and how they will impact on disability in the older population R. Matthews, C. Jagger & MRC CFAS Background Projections of future numbers with disability
More informationDisease Therapy Management (DTM) Enhances Rheumatoid Arthritis Treatment
A WHITE PAPER BY Disease Therapy Management (DTM) Enhances Rheumatoid Arthritis Treatment Increased adherence rates deliver improved outcomes for patients FALL 2010 The Benefits of DTM for Rheumatoid Arthritis
More informationAspects of disability in rheumatoid arthritis - a five-year follow-up in the Swedish TIRA project
Linköping University Medical Dissertations No. 1063 Aspects of disability in rheumatoid arthritis - a five-year follow-up in the Swedish TIRA project Mathilda Björk Rehabilitation Medicine, Department
More informationUnderstanding Clinical Trials
Understanding Clinical Trials The UK Clinical Research Collaboration (UKCRC) is a partnership of organisations working to establish the UK as a world leader in clinical research, by harnessing the power
More informationPatient education for adults with rheumatoid arthritis (Review)
Patient education for adults with rheumatoid arthritis (Review) Riemsma RP, Kirwan JR, Taal E, Rasker HJJ This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and
More informationPrior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management
Prior Authorization, Pharmacy and Health Case Management Information The purpose of this information sheet is to provide you with details on how Great-West Life will be assessing and managing your claim
More informationMedia Release. Basel, 11 June 2009. RA patients with enhanced response identified
Media Release Basel, 11 June 2009 New data demonstrate the ability of MabThera to reduce the progression of joint damage when used as a first-line biologic treatment in rheumatoid arthritis RA patients
More informationPatient derived follow-up data (PREMs, PROMs and Work) (to be collected at 3 months)
1 Date (day/month/year) 2 Rheumatology Centre ID (to be completed by clinician) 3 Patient ID (NHS number - to be completed by clinician) Patient derived follow-up data (PREMs, PROMs and Work) (to be collected
More informationTara Stevermuer (MAppStat), Centre for Health Service Development, University of Wollongong.
ENAR - PAIN RELIEF THAT S FAST AND LASTS Tara Stevermuer (MAppStat), Centre for Health Service Development, University of Wollongong. Introducing ENAR The ENAR (Electro-Neuro-Adaptive-Regulator) is a Russian
More informationDevelopment and Validation of a Screening Questionnaire for Psoriatic Arthritis
Development and Validation of a Screening Questionnaire for Psoriatic Arthritis Dafna D. Gladman 1, Catherine T. Schentag 1, Brian D. Tom 2, Vinod Chandran 1, Cheryl F. Rosen 1 Vernon T. Farewell 2 1 University
More informationEVALUATION OF A PILOT FIT FOR WORK SERVICE
EVALUATION OF A PILOT FIT FOR WORK SERVICE Dr Julia Smedley Lead Consultant Occupational Health, University Hospital Southampton NHS Foundation Trust and Honorary Senior Lecturer, University of Southampton
More informationQuality Standards Rheumatoid Arthritis
Quality Standards Rheumatoid Arthritis Minutes of the TEG 2 meeting held on 5 th November at the NICE offices in Manchester Attendees Topic Expert Group Members Robert Moots (RM), Patrick Kiely (PK), Diana
More informationDOCTOR DISCUSSION GUIDE FOR RHEUMATOID ARTHRITIS
DOCTOR DISCUSSION GUIDE FOR RHEUMATOID ARTHRITIS Talking your Doctor About Rheumatoid Arthritis Preparing for your Doctor s Appointment Early and aggressive treatment can help you forestall the joint damage
More informationUsing Monitoring and Evaluation to Improve Public Policy
SRA Workshop 10 March 2008 British Library Conference Centre, London Using Monitoring and Evaluation to Improve Public Policy Philip Davies, PhD American Institutes for Research Oxford England and Washington,
More informationNUTRITION SCREENING SURVEY IN THE UK AND REPUBLIC OF IRELAND IN 2011
NUTRITION SCREENING SURVEY IN THE UK AND REPUBLIC OF IRELAND IN 2011 A Report by the British Association for Parenteral and Enteral Nutrition (BAPEN) HOSPITALS, CARE HOMES AND MENTAL HEALTH UNITS NUTRITION
More informationThe RADICALS trial Radiotherapy Timing Randomisation (RADICALS-RT) Clinical trial of treatment after surgery for prostate cancer
Stoke Mandeville Hospital Mandeville Road Aylesbury Buckinghamshire HP21 8AL Tel: 01296 315 908 www.buckshealthcare.nhs.uk The RADICALS trial Radiotherapy Timing Randomisation (RADICALS-RT) Clinical trial
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 17 December 2003 CPMP/EWP/556/95 rev 1/Final COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
More informationBritish Journal of Rheumatology 1996;35:1101-1105
British Journal of Rheumatology 1996;35:1101-1105 REMISSION IN A PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS. AMERICAN RHEUMATISM ASSOCIATION PRELIMINARY REMISSION CRITERIA IN RELATION TO THE
More informationThe relationship between mental wellbeing and financial management among older people
The relationship between mental wellbeing and financial management among older people An analysis using the third wave of Understanding Society January 2014 www.pfrc.bris.ac.uk www.ilcuk.org.uk A working
More informationArthritis Research UK Epidemiology Unit
Arthritis Research UK Epidemiology Unit Qualitative research proposal to explore factors influencing acceptable risk thresholds used to recommend particular treatment options for rheumatoid arthritis.
More informationPrior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management
Prior Authorization, Pharmacy and Health Case Management Information The purpose of this information sheet is to provide you with details on how Great-West Life will be assessing and managing your claim
More informationSECTION 3. Criteria for Special Authorization of Select Drug Products. Section 3 Criteria for Special Authorization of Select Drug Products
SECTION 3 Criteria for Special Authorization of Select Drug Products Section 3 Criteria for Special Authorization of Select Drug Products CRITERIA FOR SPECIAL AUTHORIZATION OF SELECT DRUG PRODUCTS The
More informationRheumatoid Arthritis
A Self-determination theory based intervention to promote autonomous motivation for physical activity engagement among patients with Rheumatoid Arthritis Sally Fenton, PhD Research Fellow School of Sport,
More informationBig Data for Population Health
Big Data for Population Health Prof Martin Landray Nuffield Department of Population Health Deputy Director, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery University of Oxford
More informationPrevalence of alcohol consumption among Rheumatoid Arthritis patients on Methotrexate and impact on liver function tests
Prevalence of alcohol consumption among Rheumatoid Arthritis patients on Methotrexate and impact on liver function tests Christine Iannaccone, MPH, Michelle Frits, Jing Cui, PhD, Michael Weinblatt MD,
More informationFATIGUE IN RHEUMATOID ARTHRITIS
FATIGUE IN RHEUMATOID ARTHRITIS RESEARCH STRATEGY MEETING REPORT 9th & 10th November 2008 Chancellor s Conference Centre, University of Manchester Arthritis Research Campaign Page 1 CONTENTS Summary...
More informationRheumatoid Arthritis foot health education survey for practitioners
Rheumatoid Arthritis foot health education survey for practitioners Showing 42 of 42 responses Showing all responses Showing all questions Section 1 1 Are you Male? 11 (26.2%) Female? 31 (73.8%) 2 What
More informationDisclosure. I have the following relationships with commercial interests:
Disclosure Electra Paskett, Ph.D., MPH I have the following relationships with commercial interests: Merck Research grant, in-kind donation Pfizer Stock ownership Meridian Bioscience Stock ownership A
More informationTo achieve this aim the specific objectives of this PhD will include:
PhD Project Proposal - Living well with dementia: a PhD programme to develop a complex intervention that integrates healthcare for people with dementia 1. Background to the study There are 800,000 people
More informationSmoking and Rheumatoid Arthritis: how to deliver brief smoking cessation advice
Smoking and Rheumatoid Arthritis: how to deliver brief smoking cessation advice Offering brief advice to stop smoking is the most cost-effective and clinically proven preventative action a healthcare professional
More informationElectronic Medical Records
Electronic edical Records ER REQUIREETS SPECIFICATIO FOR RHEUATOLOGY DRAFT APPROVED Date: 2014-03 Version: 1.0 2007-2014 OntarioD Inc. All rights reserved TABLE OF COTETS TABLE OF COTETS 2 GLOSSARY 3 1.
More informationManagement Information
Management Information Initial Teacher Training Performance Profiles: academic year 2012 to 2013 Date 23 October 2014 Coverage England Theme Initial Teacher Training Issued by Department for Education,
More informationThe ACC 50 th Annual Scientific Session
Special Report The ACC 50 th Annual Scientific Session Part Two From March 18 to 21, 2001, physicians from around the world gathered to learn, to teach and to discuss at the American College of Cardiology
More informationTreatment of Severe Rheumatoid Arthritis
Treatment of Severe Rheumatoid Arthritis Zhanguo Li Department of Rheumatology and Immunology, People s Hospital Beijing University Medical School, China Contents Background Challenges Treatment strategies
More informationPrognostic factors in rheumatoid arthritis
Prognostic factors in rheumatoid arthritis Thesis Éva Palkonyai M.D. Semmelweis University, Budapest School of Ph.D. Studies Supervisor: Péter Gergely MD, D.Sci Budapest 2006. 1 Contents 1. Introduction
More informationVersion History. Previous Versions. Drugs for MS.Drug facts box fampridine Version 1.0 Author
Version History Policy Title Drugs for MS.Drug facts box fampridine Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further fields as required
More informationShared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)
Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)
More informationMental Health User/Survivor Research
VOLUME 5 ISSUE 2 Mental Health User/Survivor Research in the UK INTRODUCTION A Policy Briefing (Extended Version) Since 1997 the Mental Health Foundation has played a key role in supporting and promoting
More informationTransforming the patient experience with telehealth in Europe : "Applying Evidence-Based Medicine in Telehealth"
Transforming the patient experience with telehealth in Europe : "Applying Evidence-Based Medicine in Telehealth" George E. Dafoulas, MD, MBA in HSM, PhDc etrikala, Municipality of Trikala 5 th Regional
More information